Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.

OBJECTIVES: To estimate the seroprevalence of Chlamydia trachomatis (CT), herpes simplex type-2 (HSV2), hepatitis C (HCV), Epstein-Barr virus (EBV) and nine human papilloma virus (HPV) types, and investigated factors associated with the seropositivity among men from three countries (Brazil, Mexico and U.S). METHODS: Archived serum specimens collected at enrollment for n = 600 men were tested for antibodies against CT, HSV2, HCV, EBV, and 9-valent HPV vaccine types (6/11/16/18/31/33/45/52/58) using multiplex serologic assays. Socio-demographic, lifestyle and sexual behavior data at enrollment were collected through a questionnaire. RESULTS: Overall, 39.3% of the men were seropositive for CT, 25.4% for HSV2, 1.3% for HCV, 97.3% for EBV, 14.0% for at least one of the seven oncogenic HPV (types: 16/18/31/33/45/52/58), and 17.4% for HPV 6/11. In the unadjusted models, age, race, smoking, sexual behavior variables, and seropositivity for high-risk HPV were significantly associated with the seropositivity for CT. In multivariable analyses, self-reported black race, higher numbers of lifetime female/male sexual partners, current smoking, and seropositivity to high-risk HPV were significantly associated with increased odds of CT seropositivity. Odds of HSV2 seroprevalence were elevated among older men and those seropositive for high risk HPV. CONCLUSION: Exposure to STIs is common among men. Prevention and screening programs should target high-risk groups to reduce the disease burden among men, and to interrupt the disease transmission to sexual partners.

Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study.

BACKGROUND: In the Netherlands, there are strong disparities in Chlamydia trachomatis (CT) prevalence between ethnic groups. The current study aims to identify whether socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior may explain differences in CT seroprevalence between ethnic groups. METHODS: We used 2011-2014 baseline data of the HELIUS (HEalthy LIfe in an Urban Setting) study, a multi-ethnic population-based cohort study in Amsterdam, the Netherlands, including participants from Dutch, African Surinamese, South-Asian Surinamese, Ghanaian, Moroccan and Turkish origin. For this analysis, we selected sexually active, heterosexual participants aged 18-34 years old. CT seroprevalence was determined using a multiplex serology assay. The CT seroprevalence ratios between different ethnicities are calculated and adjusted for potential indicators of socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior. RESULTS: The study population consisted of 2001 individuals (52.8% female) with a median age of 28 years (IQR 24-31). CT seropositivity differed by ethnicities and ranged from 71.6% (African Surinamese), and 67.9% (Ghanaian) to 31.1% (Turkish). The CT seroprevalence ratio of African Surinamese was 1.72 (95% CI 1.43-2.06) and 1.52 (95% CI 1.16-1.99) of Ghanaian as compared to the Dutch reference group, after adjustment for socioeconomic status, sexual risk behavior and sexual healthcare seeking behavior. CONCLUSIONS: Indicators of socioeconomic status, sexual risk behavior, and sexual health seeking behavior could not explain the higher CT seroprevalence among African Surinamese and Ghanaian residents of Amsterdam.

Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by Chlamydia.

The presence of the single nucleotide polymorphisms in exon 1 of the mannose-binding lectin 2 (MBL2) gene was evaluated in a sample of 159 patients undergoing coronary artery bypass surgery (71 patients undergoing valve replacement surgery and 300 control subjects) to investigate a possible association between polymorphisms and heart disease with Chlamydia infection. The identification of the alleles B and D was performed using real time polymerase chain reaction (PCR) and of the allele C was accomplished through PCR assays followed by digestion with the restriction enzyme. The comparative analysis of allelic and genotypic frequencies between the three groups did not reveal any significant difference, even when related to previous Chlamydia infection. Variations in the MBL plasma levels were influenced by the presence of polymorphisms, being significantly higher in the group of cardiac patients, but without representing a risk for the disease. The results showed that despite MBL2 gene polymorphisms being associated with the protein plasma levels, the polymorphisms were not enough to predict the development of heart disease, regardless of infection with both species of Chlamydia.

Mannose-binding lectin 2 (Mbl2) gene polymorphisms are related to protein plasma levels, but not to heart disease and infection by Chlamydia

The presence of the single nucleotide polymorphisms in exon 1 of the mannose-binding lectin 2 (MBL2) gene was evaluated in a sample of 159 patients undergoing coronary artery bypass surgery (71 patients undergoing valve replacement surgery and 300 control subjects) to investigate a possible association between polymorphisms and heart disease with Chlamydia infection. The identification of the alleles B and D was performed using real time polymerase chain reaction (PCR) and of the allele C was accomplished through PCR assays followed by digestion with the restriction enzyme. The comparative analysis of allelic and genotypic frequencies between the three groups did not reveal any significant difference, even when related to previous Chlamydia infection. Variations in the MBL plasma levels were influenced by the presence of polymorphisms, being significantly higher in the group of cardiac patients, but without representing a risk for the disease. The results showed that despite MBL2 gene polymorphisms being associated with the protein plasma levels, the polymorphisms were not enough to predict the development of heart disease, regardless of infection with both species of Chlamydia.

Optimization of candidate proteins for serological screening of Chlamydia trachomatis infection.

The aim of this study was to optimize candidate antigen proteins for serological screening of Chlamydia trachomatis infection. C. trachomatis positive serum and swabs of genital secretions were collected from 50 patients in the Tianjin Medical University General Hospital, as well as from 30 patients negative for C. trachomatis. Samples were assessed by colloidal gold assay in a sexually transmitted disease clinic as follows: serum antibodies for eight kinds of C. trachomatis immunodominant proteins (Pgp3, CPAF, CT143, CT101, CT694, CT875, CT813, and IncA) were detected, and two traditional gold standards, immunofluorescence and C. trachomatis cell culture of genital secretions, were used for comparison in order to determine the antigen protein combinations with the highest sensitivity and specificity. Of the 50 samples that tested positive for C. trachomatis infection by colloidal gold assay, 44 tested positive by micro-immunofluorescence, whereas 6 tested negative. In contrast, 14 samples tested positive by cell culture, whereas 36 tested negative. Serological results of the immunodominant protein combination of Pgp3, CT694, and CT875 shared positive coincidence rates of 97.73 and 92.86% with C. trachomatis micro-immunofluorescence and cell culture, respectively. No antibodies of the three proteins were detected in the 30 C. trachomatis samples that tested negative by colloidal gold assay; these samples also tested negative in C. trachomatis genital secretion culture. Overall, the combination of the three immunodominant proteins Pgp3, CT694, and CT875 had good sensitivity and specificity for serological screening of C. trachomatis infection, and the process was simple and easy to apply.

[Serological evidence of infection by three species of Chlamydia in pregnant women in Mexico]. / Evidencia serológica de infección por tres especies de Chlamydia en mujeres embarazadas.

UNLABELLED: Background: Chlamydiales are obligate intracellular pathogens causing a wide range of diseases in humans and animals. BACKGROUND: Chlamydiales are obligate intracellular pathogens causing a wide range of diseases in humans and animals. OBJECTIVE: To evaluate the seroprevalence of IgG antibodies to Chlamydophila psittaci, Chlamydophila pneumoniae and Chlamydia trachomatis in a group of pregnant women few hours before resolution of gestation, thus allowing for assessment of the potential effects in their pregnancy outcomes. MATERIAL AND METHODS: A cross-sectional study was done involving 110 hospitalized women for pregnancy resolution in two secondary care hospitals, one of Mexico City and other of Cuernavaca, Mor. Obstetric outcomes were followed in every case. Serum antibody measures were performed by microimmunofluorescence. Possible associations between seropositivity and pregnancy outcomes were analyzed. RESULTS: 110 pregnant women were studied, 85 were seropositive for any of the species (77.3%), of which 39 (46%) had antibodies to the three species, 27 against two (32%) and 19 (22%) against one. No associations of serologic results with obstetric complications were observed in these pregnant women. High socioeconomic status was found as a risk factor for seropositivity against C trachomatis. CONCLUSIONS: This study reveals high exposure to three species of Chlamydiaceae in Mexican pregnant women. Demonstrating complex interactions in two different places where all species are present. No correlation was found between seropositivity towards these Chlamydia species and pregnancy complications.

Prevalence and molecular identification of Chlamydia abortus in commercial dairy goat farms in a hot region in Mexico.

The aim of this study was to determine the seroprevalence and presence of Chlamydia abortus in Saanen breed female goats from commercial dairy goat farms under intensive production in the municipality of Guanajuato, Mexico. Sera were collected to determine the prevalence of anti-C. abortus IgG antibodies using recombinant enzyme-linked immunosorbent assay (rELISA) and cell culture. Polymerase chain reaction (PCR) was used to prove the presence of the pathogen in swab samples collected from the vagina and rectum of selected animals. Additionally, foetal tissue samples from a sudden abortion were collected. C. abortus prevalence in female goats of commercial milking farms sampled in Guanajuato, Mexico, was 4.87% (n = 246). Seropositive animals were found in six out of nine (66.6%) dairy goat farms sampled, and prevalence among animals in individual farms ranged between 3.44 and 13.51%. C. abortus was detected using PCR in spleen tissue from the aborted foetus. PCR-based detection, as well as isolation from vaginal and rectal swabs, was not possible in the present study. Isolation through cell culture was also unsuccessful from aborted foetal tissue samples. In conclusion, the results from rELISA and PCR show that C. abortus is present in dairy goat farms in the state of Guanajuato, Mexico.

[Anti-C. trachomatis IgG antibodies levels in serum to identify infertility caused by tubal damage]. / Evaluación de los niveles séricos de anticuerpos IgG anti-Chlamydia trachomatis para el diagnóstico de infertilidad por factor tubario.

OBJECTIVE: To identify the serologic titers of anti-Chlamydia trachomatis IgG (Ab) antibodies that could be used to differentiate tubal damage infertility from other causes of subfertility in a group of Mexican women. MATERIAL AND METHODS: This was a prospective, longitudinal and analytical study of 147 women selected in a non-random way. The women were classified into three sub-groups: 1) infertile women with tubal occlusion detected by laparoscopy (n = 58); 2) infertile women with alternative causes of subfertility (n = 50), and 3) fertile women for the control group (n = 39). An assay of indirect immunofluorescence was performed on all infertile women (n = 108). The results obtained were compared with the laparoscopic and hormonal analyses carried out on the 108 infertile women. The statistical analysis included a model in ROC Curve and Logistical Regression. RESULTS: The results showed that the titer 1:256 is able to differentiate fertile women from infertile women. Moreover, in the adjusted analysis, the titer 1:512 was able to identify infertile women with tubal occlusion (OR 2.6, CI 95% 1.24, 5.4), with a sensibility of 40% and a specificity of 90%. Positive and negative predictive values were 85% and 50%, respectively and the positive and negative likelihood ratios were 3.85 and 0.67, respectively. The pattern of the ROC curve confirmed a court value of 1:512, with an area under the curve of 62.2% (CI 95%: 53.4-72%). CONCLUSION: A titer greater or equal to 1:512 of anti-C. trachomatis IgG antibodies is useful in the identification of tubal factor infertility.

[Prevalence of anti-Chlamydia trachomatis and anti-Neisseria gonorrhoeae antibodies in Mexican populations]. / Prevalencia de anticuerpos anti-Chlamydia trachomatis y anti-Neisseria gonorrhoeae en grupos de individuos de la población mexicana.

OBJECTIVE: To estimate the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection in groups of individuals at different risks of sexually transmitted infections (STI). MATERIAL AND METHODS: Between January 1992 and December 1993, a cross-sectional multicentric study was carried out at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (National Institute of Medical Sciences and Nutrition "Salvador Zubirán") in Mexico City. The study population consisted of 945 reproductive age subjects (585 females and 360 males). Low and high risk groups were classified according to their risk for STI. High risk groups included infertile women with tubal damage, women with a history of ectopic pregnancy or abortion, infertile men, HIV/AIDS patients, homo- or bisexual men, and female commercial sex workers. Low risk groups included primigravidae, fertile men, and infertile women with no tubal damage. Serum anti-NG and anti-CT IgG and IgA were determined, in duplicate by immune-enzymatic assay, using as antigens NG pili and the LI fraction of CT. Descriptive analysis is presented as percentages. RESULTS: NG prevalence in females was 13.7% by IgG and 14.3% by IgA. CT prevalence was 11.4% by IgG and 4.4% by IgA. In males, NG prevalences were 3.3% and 13.3% by IgG and IgA, respectively; CT prevalences were 7.2% and 5.5%, respectively. In commercial sex workers, NG prevalences were 31.2% by IgG and 28.4% by IgA, and CT 25.0% and 5.7% by IgG and IgA, respectively. In women with infertility due to tubal damage the prevalences of NG were 5.6% and 9.8%, respectively, and those of CT were 8.4% and 1.4%, respectively. In 110 young primigravid NG prevalences were 4.5% and 10.0%, respectively, and CT 3.6% and 9.1%. CONCLUSIONS: These data confirm the high prevalence of Neisseria gonorrhoeae and Chlamydia trachomatis in female commercial sex workers and homo- or bisexual men, but not in other high-risk groups like infertile women or women with a history of ectopic pregnancy or abortion. The English version of this paper is available at:http://www.insp.mx/salud/index.html.

Prevalencia de anticuerpos anti-Chlamydia trachomatis y anti-Neisseria gonorrhoeae en grupos de individuos de la población mexicana / Prevalence of antibodies against Chlamydia trachomatis and Neisseria gonorrhoeae in Mexican populations

OBJETIVO: Estimar la prevalencia de infección por Chlamydia trachomatis (CT) y Neisseria gonorrhoeae (NG) en grupos de individuos con diferente riesgo para infecciones de transmisión sexual. MATERIAL Y MÉTODOS: Estudio transversal multicéntrico efectuado en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, de la Ciudad de México, de enero de 1992 a diciembre de 1993, en el que se estudiaron 945 individuos en edad reproductiva, 585 mujeres y 360 hombres. Según su riesgo para infecciones de transmisión sexual se clasificaron en grupos de alto y bajo riesgo. Los de alto riesgo incluyeron mujeres infértiles con daño tubario, mujeres con embarazo ectópico o aborto, hombres infértiles, pacientes con VIH/SIDA, hombres homo o bisexuales y trabajadoras del sexo comercial (TSC). Los de bajo riesgo: mujeres primigestas, hombres fértiles y mujeres infértiles sin daño tubario. Se determinó en duplicado IgG e IgA anti-NG y anti-CT en suero, por análisis inmunoenzimático, utilizando como antígeno el pili de NG y la fracción L1 de CT. Se calcularon porcentajes. RESULTADOS: En mujeres la prevalencia para NG fue IgG 13.7 por ciento e IgA 14.3 por ciento, y para CT fue IgG 11.4 por ciento e IgA 4.4 por ciento. En hombres, NG 3.3 por ciento y 13.3 por ciento, respectivamente, y para CT 7.2 por ciento y 5.5 por ciento, respectivamente. En TSC se encontró NG en 31.2 por ciento y 28.4 por ciento, respectivamente, y para CT 25.0 por ciento y 5.7 por ciento, respectivamente. En mujeres con infertilidad por daño tubario, NG 5.6 por ciento y 9.8 por ciento, respectivamente, y CT 8.4 por ciento y 1.4 por ciento, respectivamente. En 110 primigestas jóvenes, NG 4.5 por ciento y 10.0 por ciento, respectivamente, y CT 3.6 por ciento y 9.1 por ciento, respectivamente. CONCLUSIONES: Estos datos confirman la prevalencia elevada de Neisseria gonorrhoeae y Chlamydia trachomatis en trabajadoras del sexo comercial y en hombres homo/bisexuales, pero no en otros grupos de alto riesgo como las mujeres infértiles, con aborto o embarazo ectópico.

Epidemiología serológica de chlamydia trachomatis en mujeres que asisten a un servicio de planificación familiar / Serologic epidemiology of chlamydia trachomatis infection among fertile women attending a birth control facility

C. trachomatis is an important cause of sexually transmitted diseases, being mainly associated to cervicitis or urethritis among female and male patients, respectively. This study was designed to evaluate the frecuency of C. trachomatis infection among female patients attending a bith control facility using chlamydia IgG and IgM antibody detection, and to correlate this findings with the presence of C. trachomatis at the endocervix. Two hundred fertile women attending a hostital associated birth control facitity were evaluated by indirect microimmunofluorescence (IMIF) to detect circulating antibodies and with direct microimmunofluorescence (DMIF) to detect C. trachomatis in endocervix. C. trachomatis was present in 24 percent (44/200) of endocervical samples. IgG antibodies were equally prevalent in both DMIF positive group had higher antibody titers than the negative group (54,1 vs 32,9 percent, p < 0,05). Moreover, the DMIF positive group was associated with a higher frecuency of chlamydia IgM antibodies than the DMIF negative group. (97,5 vs 4,6 percent, p < 0,0001). These results indicate that C. trachomatis is a frequent agent of infection among women asking to be included in a birth control programm and also suggest that epidemiological surveillance studies are needed

Seroepidemiology of chlamydial infection among a sexually-active population in Barbados

During a two-year period, sera from 1179 patients with urogenital tract symptoms and from 256 controls were tested for IgG and IgA antibodies to Chlamydia trachomatis, using a commercially prepared indirect immunoperoxidase assay. Of the patient sera, 1051 (89 percent) were from female patients and 128 (11 percent) were from males. Specimens were received from patients attending private practitioners (424), government polyclinics (348), the Queen Elizabeth Hospital (206), the Barbados Family Planning Association (117) and various other source (84). Nine hundred and fifty-nine of specimens (81 percent) from all patients had IgG titres of 64 or greater, and 441 (37 percent) had IgA titres of 16 or greater. A lower proportion of male patients (43 percent) than female patients (61 percent) had IgG titres of 128 or greater. Among 76 control females attending the antenatal clinic, IgG were detected in 76 percent and IgA in 16 percent, while among 75 adult blood donors, IgG was detected in 70 percent and IgA in 39 percent. A group comprising 97 asymptomatic children aged 9 months to 13 years, and 8 adolescents aged 14 - 18 years was also studied. IgG antibodies (titre

Seroepidemiology of chlamydial infection among a sexually-active population in Barbados

During a two-year period, sera from 1179 patients with urogenital tract symptoms and from 256 controls were tested for IgG and IgA antibodies to Chlamydia trachomatis, using a commercially prepared indirect immunoperoxidase assay. Of the patient sera, 1051 (89//) were from female patients and 128 (11//) were from males. Specimens were received from patients attending private practitioners (424), government polyclinics (348), the Queen Elizabeth Hospital (206), the Barbados Family Planning Association (117) and various other source (84). Nine hundred and fifty-nine of specimens (81//) from all patients had IgG titres of 64 or greater, and 441 (37//) had IgA titres of 16 or greater. A lower proportion of male patients (43//) than female patients (61//) had IgG titres of 128 or greater. Among 76 control females attending the antenatal clinic, IgG were detected in 76//and IgA in 16//, while among 75 adult blood donors, IgG was detected in 70//and IgA in 39//. A group comprising 97 asymptomatic children aged 9 months to 13 years, and 8 adolescents aged 14 - 18 years was also studied. IgG antibodies (titre ñ 64) were detected in 13.4//of children and in 50//of the adolescents. IgA antibodies were detected in only 1//of children and adolscents. Antibodies were not detected in children under the age of 5 years. The detection of antibodies by indirect immunoperoxidase assay in such a high proportion of the population suggests that this method is of little value for diagnosis of infection with Chlamydia trachomatis

Chlamydial infection in the Amazon region of Brazil.

The prevalence of antibodies to Chlamydia was determined in 9 population groups with different risk levels for sexually transmitted diseases in Belém, Pará state, Brazil. 583 serum samples were examined by the indirect immunofluorescence test. The prevalence rates varied from 33.3% in patients attending a sexually transmitted disease clinic to 97.1% in Parakana Indians. One or more pathogens were found in 55 of 86 patients presenting a clinical picture of urethritis; C. trachomatis was isolated from 11% (6/55) of these cases by inoculation to McCoy cell cultures, accounting for 30% (6/20) of the cases of non-gonococcal urethritis. C. trachomatis was isolated from one of 28 female patients (3.6%) attending gynaecology and obstetrics outpatient clinics. The positive patients had no symptom or complaint that would have suggested the diagnosis.